2021 annual enrollment for faculty and staff is this month
UC’s annual benefit enrollment begins on Nov. 1 and ends on Nov. 30
As University of Cincinnati faculty and staff, you are encouraged to Choose Well for your benefits next year for 2021. Benefit elections will be made via the Employee Self Service or ESS. As you prepare to make your 2021 benefit choices, we encourage you to review the resources available to you on the Annual Enrollment Bearcats Landing site (UC login required). Detailed information on what’s changing, what’s new, what’s staying the same, and more can be found there as well.
Virtual, live town hall sessions and one-on-one calls with a Benefits representative are available to help you choose well throughout November. Take a few minutes to review the Annual Enrollment Quickstart Guide and try the Annual Enrollment Challenge!
Choose Well - UC Benefits and Wellness Helping You Navigate the Pathways of 2021!
Questions?
Reach out to the UC Benefits team at benefits@uc.edu.
Related Stories
UC faculty and staff among Rising Star leadership honorees
January 5, 2026
Two UC faculty and staff members are among this year's Rising Star leadership program sponsored by YWCA Greater Cincinnati. Kelli Beecher, assistant professor in the UC College of Nursing, and Brittany Bibb, assistant director of programs and operations in the UC Division of Student Affairs, are among the emerging leaders of 2026. They were featured in the publication Movers & Makers.
What's behind the mysterious rise of migraines?
January 5, 2026
Weather patterns such as extreme heat and storm conditions have been linked to migraine attacks, and research shows those environmental conditions are becoming more common. As National Geographic recently reported, one of the leading theories behind this mysterious rise is that climate change may be playing a role.
Top six 2025 nephrology drug approvals
January 5, 2026
“2025 has been a landmark year for kidney disease therapeutics, marked by a comprehensive slate of FDA approvals covering endothelin-receptor blockade, complement inhibition, GLP-1-based metabolic protection, and B-cell-directed therapy,” Prakash Gudsoorkar, MD, associate professor of clinical medicine at the University of Cincinnati College of Medicine and staff nephrologist at UC Health, recently told MedCentral.